INTERCEPT PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INTERCEPT PHARMACEUTICALS IN NOTE 3.250% 7/0, CUSIP 45845PAD0.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INTERCEPT PHARMACEUTICALS IN NOTE 3.250% 7/0, CUSIP 45845PAD0.